Search Results - "Glehen, O."

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials by Coccolini, F, Cotte, E, Glehen, O, Lotti, M, Poiasina, E, Catena, F, Yonemura, Y, Ansaloni, L

“…Abstract Introduction An important component of treatment failure in gastric cancer (GC) is cancer dissemination within the peritoneal cavity and nodal…”
Get full text

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI) by Bushati, M., Rovers, K.P., Sommariva, A., Sugarbaker, P.H., Morris, D.L., Yonemura, Y., Quadros, C.A., Somashekhar, S.P., Ceelen, W., Dubé, P., Li, Y., Verwaal, V.J., Glehen, O., Piso, P., Spiliotis, J., Teo, M.C.C., González-Moreno, S., Cashin, P.H., Lehmann, K., Deraco, M., Moran, B., de Hingh, I.H.J.T.

“…At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive…”
Get full text

Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? by Chia, C. S., You, B., Decullier, E., Vaudoyer, D., Lorimier, G., Abboud, K., Bereder, J.-M., Arvieux, C., Boschetti, G., Glehen, O.

“…Background Peritoneal carcinomatosis is an increasingly common finding in gastric carcinoma. Previously, patients were treated as terminal, and median survival…”
Get full text

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up by Kusamura, S., Kepenekian, V., Villeneuve, L., Lurvink, R.J., Govaerts, K., De Hingh, I.H.J.T., Moran, B.J., Van der Speeten, K., Deraco, M., Glehen, O., Barrios-Sanchez, Pedro, Baumgartner, Joel M., Ben-Yaacov, Almog, Bertulli, Rosella, Cashin, Peter, Cecil, Tom, Dayal, Sanjeev, De Simone, Michele, Foster, Jason M., Goere, Diane, Lehmann, Kuno, Li, Yan, Loggie, Brian W., Mohamed, Faheez, Morris, David L., Nissan, Aviram, Piso, Pompiliu, Pocard, Marc, Rau, Beate, Reymond, Marc A., Sideris, Lucas, Spiliotis, John D., Sugarbaker, Paul H., Verwaal, Victor J., Wilson, Malcom S., Yonemura, Yutaka, Yu, Yang

Get full text

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin by Laplace, N., Kepenekian, V., Friggeri, A., Vassal, O., Ranchon, F., Rioufol, C., Gertych, W., Villeneuve, L., Glehen, O., Bakrin, N.

“…Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal…”
Get full text

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment by Govaerts, K., Lurvink, R.J., De Hingh, I.H.J.T., Van der Speeten, K., Villeneuve, L., Kusamura, S., Kepenekian, V., Deraco, M., Glehen, O., Moran, B.J., Barrios-Sanchez, Pedro, Baumgartner, Joel M., Ben-Yaacov, Almog, Bertulli, Rosella, Cashin, Peter, Cecil, Tom, Dayal, Sanjeev, De Simone, Michele, Foster, Jason M., Goere, Diane, Lehmann, Kuno, Li, Yan, Loggie, Brian W., Mohamed, Faheez, Morris, David L., Nissan, Aviram, Piso, Pompiliu, Pocard, Marc, Rau, Beate, Reymond, Marc A., Sideris, Lucas, Spiliotis, John D., Sugarbaker, Paul H., Verwaal, Victor J., Wilson, Malcom S., Yonemura, Yutaka, Yu, Yang

“…Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating from a perforated epithelial tumour of the appendix. Given its rarity,…”
Get full text

Evaluation of the peritoneal carcinomatosis index with CT and MRI by Dohan, A., Hoeffel, C., Soyer, P., Jannot, A. S., Valette, P.‐J., Thivolet, A., Passot, G., Glehen, O., Rousset, P.

“…Background The aim was to determine the incremental value of MRI compared with CT in the preoperative estimation of the peritoneal carcinomatosis index (PCI)…”
Get full text

Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22) by Karoui, M., Rullier, A., Piessen, G., Legoux, J. L., Barbier, E., De Chaisemartin, C., Lecaille, C., Bouche, O., Ammarguellat, H., Brunetti, F., Prudhomme, M., Regimbeau, J. M., Glehen, O., Lievre, A., Portier, G., Hartwig, J., Goujon, G., Romain, B., Lepage, C., Taieb, J.

“…BACKGROUND:Perioperative chemotherapy has proven valuable in several tumors, but not in colon cancer (CC). OBJECTIVE:The aim of this study was to evaluate the…”
Get full text

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer by Gouy, S, Ferron, G, Glehen, O, Bayar, A, Marchal, F, Pomel, C, Quenet, F, Bereder, J.M, Le Deley, M.C, Morice, P

“…Abstract Purpose Hyperthermic intraperitoneal chemotherapy (HIPEC) may improve the outcome of patients with initially unresectable ovarian cancer who are…”
Get full text

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients by Bakrin, N., Cotte, E., Golfier, F., Gilly, F. N., Freyer, G., Helm, W., Glehen, O., Bereder, J. M.

“…Background Epithelial ovarian carcinoma is the main cause of death from gynaecological cancers in the western world. The initial response rate to the frontline…”
Get full text

Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor? by Aubert, M., Mege, D., Goere, D., Ezzedine, W., Pocard, M., Quenet, F., Wernert, R., Glehen, O., Pirro, N.

“…Obesity is a public health concern with an increasing occurrence worldwide. Literature regarding impact of obesity on results after management of peritoneal…”
Get full text

Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis by Coccolini, F, Catena, F, Glehen, O, Yonemura, Y, Sugarbaker, P.H, Piso, P, Montori, G, Ansaloni, L

“…Abstract Introduction The completeness of cytoreduction has been considerated as fundamental in increasing the life expectancy in patients with peritoneal…”
Get full text

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry by Villeneuve, L, Passot, G, Glehen, O, Isaac, S, Bibeau, F, Rousset, P, Gilly, F N

“…Rare peritoneal cancers represent complex clinical situations requiring a specific and multidisciplinary management. Because of their rarity, lack of awareness…”
Get full text

Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG‐RENAPE) by Passot, G., Dumont, F., Goéré, D., Arvieux, C., Rousset, P., Regimbeau, J.‐M., Elias, D., Villeneuve, L., Glehen, O., Abba, J., Abboud, K., Carere, S., Durand‐Fontanier, S., Eveno, C., Facy, O., Gelli, M., Gilly, F.‐N., Karoui, M., Lo Dico, R., Ortega‐Deballon, P., Pocard, M., Quenet, F., Rat, P., Sabbagh, C., Sgarbura, O., Thibaudeau, E., Vaudoyer, D., Wernert, R.

“…Background The peritoneal cancer index (PCI) is a comparative prognostic factor for colorectal peritoneal metastasis (CRPM). The ability of laparoscopy to…”
Get full text

Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? by Honoré, C, Atallah, V, Mir, O, Orbach, D, Ferron, G, LePéchoux, C, Delhorme, J B, Philippe-Chomette, P, Sarnacki, S, Msika, S, Terrier, P, Glehen, O, Martelli, H, Minard-Colin, V, Bertucci, F, Blay, J Y, Bonvalot, S, Elias, D, LeCesne, A, Sargos, P

“…Desmoplastic Small Round Cell Tumor (DSRCT) is a rare disease affecting predominantly children and young adults and for which the benefit of hyperthermic…”
Get full text

A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis by Arjona-Sanchez, A., Esquivel, J., Glehen, O., Passot, G., Turaga, K. K., Labow, D., Rufian-Peña, S., Morales, R., van der Speeten, K.

“…Background Minimally invasive surgery is playing an increasing role in the treatment of patients with gastrointestinal and gynaecological malignancies as the…”
Get full text

Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study by GLEHEN, O, KWIATKOWSKI, F, GUTMAN, M, TENTES, A. A. K, LORIMIER, G, BERNARD, J. L, BEREDER, J. M, PORCHERON, J, GOMEZ-PORTILLA, A, SHEN, P, DERACO, M, RAT, P, SUGARBAKER, P. H, ELIAS, D, LEVINE, E. A, DE SIMONE, M, BARONE, R, YONEMURA, Y, CAVALIERE, F, QUENET, F

“…The three principal studies dedicated to the natural history of peritoneal carcinomatosis (PC) from colorectal cancer consistently showed median survival…”
Get full text

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients by Bakrin, N, Bereder, J.M, Decullier, E, Classe, J.M, Msika, S, Lorimier, G, Abboud, K, Meeus, P, Ferron, G, Quenet, F, Marchal, F, Gouy, S, Morice, P, Pomel, C, Pocard, M, Guyon, F, Porcheron, J, Glehen, O

“…Abstract Background Despite a high response rate to front-line therapy, prognosis of epithelial ovarian carcinoma (EOC) remains poor. Approaches that combine…”
Get full text

Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies by Passot, G, Bakrin, N, Isaac, S, Decullier, E, Gilly, F.N, Glehen, O, Cotte, E

“…Abstract Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the only curative treatment for many…”
Get full text

Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients by Honoré, C., Delhorme, J.B., Nassif, E., Faron, M., Ferron, G., Bompas, E., Glehen, O., Italiano, A., Bertucci, F., Orbach, D., Pocard, M., Quenet, F., Blay, J.Y., Carrere, S., Chevreau, C., Mir, O., Le Cesne, A.

“…Despite being associated with a very poor prognosis, long-term survivors across all series of Desmoplastic Small Round Cell Tumor (DSRCT) have been reported…”
Get full text